Conformis to be acquired by restor3d for $2.27 per share in cash

restor3d and Conformis announced that they have entered into a definitive merger agreement under which restor3d, a personalized 3D-printed orthopedic company, will acquire all outstanding shares of common stock of Conformis at $2.27 per share in cash, which represents an approximate 96% premium to the closing price of Conformis stock on June 22. Conformis’ board of directors, having determined that the transaction is in the best interests of the company’s stockholders, has unanimously approved the transaction. The closing of this transaction is expected by the end of Q3 and is subject to approval by Conformis’ stockholders and other customary closing conditions.